Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

International Flavors & Fragrances Inc.

Start price
Target price
Perf. (%)
€106.00
08.02.21
-
08.02.22
13.26%
21.04.21

Risky Investment
buy
Morgan Stanley

Start price
Target price
Perf. (%)
€61.03
08.02.21
€77.00
08.02.22
52.66%
30.01.22

Market Leader or Top 3
Well known brand
Significant cyclical dependencies
High valuation
Ocugen Inc.

Start price
Target price
Perf. (%)
€11.35
08.02.21
€8.00
08.02.22
-30.04%
11.02.21

Stable Large shareholder and/or long term investor
Capable Management
Little innovation
Few uniques
buy
Fresenius SE & Co. KGaA

Start price
Target price
Perf. (%)
€34.83
08.02.21
€41.00
16.07.21
27.92%
16.07.21

Could be worthwhile Investment >10% per year
Fair valuation
High dividend yield expected
Small challenges to pay loans and raise capital
Grenke AG

Start price
Target price
Perf. (%)
€29.60
08.02.21
€20.00
08.02.22
1.76%
22.02.21

Some uniques
Probably not worthwhile Investment
Deficits in Management
Very bad culture
CRH Medical Corp

Start price
Target price
Perf. (%)
€3.22
08.02.21
€3.00
08.02.22
-0.62%
22.02.21

Good culture
Probably not worthwhile Investment
Little innovation
No uniques
buy
Curevac N.V.

Start price
Target price
Perf. (%)
€105.96
08.02.21
-
08.02.22
2.02%
28.04.21

Could be worthwhile Investment >10% per year
Top 10 in its market
buy
Ballard Power Systems Inc.

Start price
Target price
Perf. (%)
€32.82
08.02.21
€40.00
08.02.22
-75.16%
08.02.22

Could be very worthwhile Investment >20% year
Revenue growth > 30% per year expected
EBIT growth > 30% per year expected
Rising EBIT margin expected
buy
SAP SE

Start price
Target price
Perf. (%)
€109.26
08.02.21
€120.00
08.02.22
9.79%
29.06.21

Differentiated customer and product portfolio
Could be worthwhile Investment >10% per year
Known brand
Future proof or reliable business model
buy
Coca-Cola Co.

Start price
Target price
Perf. (%)
€41.33
08.02.21
€45.00
08.02.22
10.74%
29.03.21

Could be worthwhile Investment >10% per year
Some uniques
Top 10 in its market
Known brand
AUTO1 Group SE

Start price
Target price
Perf. (%)
€50.49
08.02.21
-
08.02.22
-48.50%
29.11.21

buy
Formycon AG

Start price
Target price
Perf. (%)
€67.20
08.02.21
-
08.02.22
-19.79%
09.02.22

buy
Xiaomi Corp.

Start price
Target price
Perf. (%)
€2.90
08.02.21
-
08.02.22
-35.41%
09.02.22

Could be worthwhile Investment >10% per year
Revenue growth > 30% per year expected
EBIT growth >5% per year expected
Netflix Inc.

Start price
Target price
Perf. (%)
€461.75
08.02.21
€165.00
08.02.22
16.86%
12.10.21

buy
Carbios S.A.

Start price
Target price
Perf. (%)
€55.30
08.02.21
-
18.01.25
-52.35%
12.01.24

Could be worthwhile Investment >10% per year
buy
Nokia Corp.

Start price
Target price
Perf. (%)
€3.57
08.02.21
€5.00
-6.41%
22.02.21

Could be very worthwhile Investment >20% year
positive Cash Flow expected
Top Rating
Leading role in innovation
buy
Atossa Genetics Inc

Start price
Target price
Perf. (%)
€3.44
08.02.21
€5.00
08.02.22
-27.31%
22.02.21

Could be worthwhile Investment >10% per year
buy
Star Equity Holdings Inc.

Start price
Target price
Perf. (%)
€3.12
08.02.21
€5.00
08.02.22
14.10%
22.02.21

Could be worthwhile Investment >10% per year
buy
InVivo Therapeutics Holdings

Start price
Target price
Perf. (%)
€32.25
08.02.21
€50.00
08.02.22
6.98%
22.02.21

Could be worthwhile Investment >10% per year
buy
Nuwellis Inc.

Start price
Target price
Perf. (%)
€7.35
08.02.21
€9.00
08.02.22
-1.36%
22.02.21

Could be very worthwhile Investment >20% year
buy
Overstock.com

Start price
Target price
Perf. (%)
€79.50
08.02.21
-
08.02.22
-13.48%
27.07.21

Stable Large shareholder and/or long term investor
EBIT decline/stagnation expected
Few uniques
Sustainability is little important
buy
eHealth Inc.

Start price
Target price
Perf. (%)
€48.35
08.02.21
-
08.02.22
16.56%
24.03.21

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
Higher EBIT margin than peer group
Fair valuation
buy
Synaptics Inc.

Start price
Target price
Perf. (%)
€98.50
08.02.21
-
08.02.22
17.77%
24.03.21

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
buy
Bill.com Holdings Inc.

Start price
Target price
Perf. (%)
€152.00
08.02.21
-
08.02.22
-20.39%
24.03.21

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Lower EBIT Margin than peer group
buy
Gamestop Corp.

Start price
Target price
Perf. (%)
€14.13
08.02.21
-
-36.12%
21.02.21

Could be very worthwhile Investment >20% year